Nikko Asset Management Americas, Inc. Veracyte, Inc. Transaction History
Nikko Asset Management Americas, Inc.
- $8.95 Billion
- Q4 2024
A detailed history of Nikko Asset Management Americas, Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 2,493,377 shares of VCYT stock, worth $85 Million. This represents 1.1% of its overall portfolio holdings.
Number of Shares
2,493,377
Previous 2,746,402
9.21%
Holding current value
$85 Million
Previous $93.5 Million
5.65%
% of portfolio
1.1%
Previous 1.08%
Shares
26 transactions
Others Institutions Holding VCYT
# of Institutions
338Shares Held
80.4MCall Options Held
212KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA8.21MShares$280 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$266 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$225 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$143 Million1.46% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$139 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.44B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...